No abstract

Relapse susceptibility in women with substance use disorders (SUDs) has been linked to the estrogen, 17b-estradiol (E2). Our previous findings in female rats suggest that the influence of E2 on cocaine seeking can be localized to the prelimbic prefrontal cortex (PrL-PFC). Here, we investigated the receptor mechanisms through which E2 regulates the reinstatement of extinguished cocaine seeking. Sexually mature female rats underwent intravenous cocaine self-administration (0.5 mg/inf; 14 3 2 h daily) and extinction, and then were ovariectomized before reinstatement testing. E2 (10 mg/kg, i.p.) alone did not reinstate cocaine seeking, but it potentiated reinstatement when combined with an otherwise subthreshold priming dose of cocaine. A similar effect was observed following intra-PrL-PFC microinfusions of E2 and by systemic or intra-PrL-PFC administration of the estrogen receptor (ER)b agonist, DPN, but not agonists at ERa or the G-protein-coupled ER1 (GPER1). By contrast, E2potentiated reinstatement was prevented by intra-PrL-PFC microinfusions of the ERb antagonist, MPP, or the GPER1 antagonist, G15, but not an ERa antagonist. Whole-cell recordings in PrL-PFC layer (L)5/6 pyramidal neurons revealed that E2 decreases the frequency, but not amplitude, of GABA A -dependent miniature IPSCs (mIPSC). As was the case with E2-potentiated reinstatement, E2 reductions in mIPSC frequency were prevented by ERb and GPER1, but not ERa, antagonists and mimicked by ERb, but not GPER1, agonists. Altogether, the findings suggest that E2 activates ERb and GPER1 in the PrL-PFC to attenuate the GABA-mediated constraint of key outputs that mediate cocaine seeking.